Clinical Trial of SARS-CoV-2 mRNA Vaccine in Chinese People
Clinical trial NCT05352867 · COMPLETED
Trial details
- NCT number
- NCT05352867
- Sponsor
- AIM Vaccine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-16
- Primary completion
- 2022-06-23
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.